Global Intragastric Balloons Market is expected to reach at a CAGR of more than 7.01% till 2021; Finds New Report

The global intragastric balloons market is expected to grow at a CAGR of more than 7.01% till 2021.

Global Intragastric Balloons Market - Strategic Assessment and Forecast till 2021 market research report considers the present scenario of worldwide intragastric balloons market and forecasts the growth of the market till 2021.

Intragastric balloons are the saline-filled silicone balloons placed in the stomach for a span of months and limits intake of food by giving the feeling of satiety. These balloons permit patients to sense fullness, controls hunger, delays gastric emptying by altering gut hormones and peptides thus reducing food intake ultimately.

The research report gives an in- depth analysis of the market growth, trends, driver and restraints associated with it. The report gives a detailed analysis of the intragastric balloons

By Geography

• Americas
• Europe Middle East and Africa (EMEA)
• Asia-Pacific (APAC)

By Countries

• Africa
• Australia
• Brazil
• Canada
• China
• France
• Germany
• India
• Italy
• Japan
• Korea
• Middle East (Saudi Arabia, Qatar, Kuwait)
• New Zealand
• Spain
• UK
• US

The report also provides market share and profiles the key vendors operating in the Worldwide Intragastric Balloons Market and also provides the detailed competitive landscape of key players.

Intragastric Balloons Market – Market size and Dynamic

The market research analyst at publisher expects the global intragastric balloons market to reach approx. US$198.56 million by 2021, growing at a CAGR of 7.01% during the forecast period 2016-2021. A large portion of the US healthcare expenditure is spent on programmes related to chronic diseases like obesity. Owing to this, the adoption of intragastric balloons is expected to propel in the U.S. to manage obesity. Europe, Middle East, and Africa (EMEA) accounts for the major share of the market.

Intragastric Balloons Market – Trends and Drivers

This market research report provides market overview of the factors driving and restraining the growth of the market. The report also outlines the key trends emerging in the market that will contribute to the growth of Intragastric Balloons Market during the forecast period. Today, intragastric balloons are used as treatment for obesity as a pre-emptive therapy, a metabolic therapy, or a primary therapy. Intragastric balloons help in weight loss and helps in recovering metabolic diseases. Factors such as large obese population, unhealthy lifestyle, short hospital stay, short recovery time, and low price of intragastric ballooning globally are driving the growth of the market.

There a short- term and long term risks and adverse effects associated with the use of intragastric balloons which is one of the major impeding challenges for the intragastric balloons market.

Intragastric Balloons Market – Geographical Analysis

The report includes the market analysis of different regions such as Americas, APAC, and Europe and MEA. The report outlines the major market share holder and the market size analysis of all the regions. Europe, Middle East and Africa (EMEA) is expected to continue dominating the intragastric balloons market in near future with a market share of approx.. 62% in 2021. In EMEA, the EU5 dominates the market with a collective share of about 91.5% in 2015 The US is the nascent market for intragastric ballooning with the first US FDA approval of intragastric ballooning in mid-2015. Mexico is likely to spur the growth of the intragastric balloons market in the Latin American region.

Intragastric Balloons – Key Market Share and Vendor Analysis

This market research profiles the major companies in the Worldwide Intragastric Ballons Market and also provides the competitive landscape and market share of key the players. The report covers the entire market outlook regarding the value chain operating within the market.

Major Players in the market

• Apollo Endoscopy Inc.
• Spatz FGIA Inc.
• Allurion Technologies Inc.
• ReShape Medical Inc.
• Hélioscopie SA
• Obalon Therapeutics Inc.

Other Prominent Vendors are

• Silimed Inc.
• Endalis
• Obalon Therapeutics Inc
• BAROnova Inc.
• Districlass Medical SA
• MEDSIL
• PlenSat, Inc.
• LIFE PARTNERS EUROPE
• Medicone
• Fengh Medical
• Phagia Technologies, Inc.
• Shandong Institute of Medical Instruments
• Tulip Medical

Why should you buy Intragastric Balloons Market Report?

The report gives reasonable answers for the following questions which leads you to know the in- depth market analysis such as

1) How has the market been performing and what are some of the current changes which are expected to change the landscape in the coming years?

2) What are the various factors that can affect the market and in what way over the next few years?

3) What are the emerging trends and challenges for the market over the next five years?

4) Which regions are going to have the largest market share and what are the factors propelling the market growth in that region?

5) Which companies are the key vendors in the market?

6) What are the strategies used by the top vendors, and what are the opportunities to grow?

7) Which companies are the emerging vendors in the market?

Spanning over 84 pages and 41 Exhibits “Global Intragastric Balloons Market - Strategic Assessment and Forecast Till 2021” report covers Research Methodology, Executive Summary, Report Coverage, Market Research Methodology, Introduction, Market Landscape, Key Market Growth Drivers, Key Market Restraints, Key Market Trends, Key Market Growth Opportunity, Value Chain Analysis, Evidence-based Research Studies, Worldwide Intragastric Balloons Market by Geography, Intragastric Balloons Market in the Americas, Intragastric Balloons Market in EMEA, Intragastric Balloons Market in APAC, Changing Regulatory Landscape in Europe, Vendor Landscape, Market Share Analysis, Competitive Landscape, Key Vendor Analysis, Summary of the Report, Appendix. This report Covered Companies - Apollo Endoscopy Inc., Spatz FGIA Inc., Allurion Technologies Inc., ReShape Medical Inc., Hélioscopie SA, Obalon Therapeutics Inc., Silimed Inc., Endalis, Obalon Therapeutics Inc, BAROnova Inc., Districlass Medical SA, Medsil, PlenSat, Inc., Life Partners Europe, Medicone, Fengh Medical, Phagia Technologies, Inc., Shandong Institute of Medical Instruments, Tulip Medical

For more information Visit at: http://mrr.cm/3Qa

Find all Healthcare Reports at: http://www.marketresearchreports.com/healthcare